Dashboard
Manage Tickers

LHLABORATORY CORP OF AMERICA ...

NYSE labcorp.com


$ 201.30 $ 1.07 (0.53 %)    

Friday, 03-May-2024 15:59:53 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 435.98 $ 8.58 (2.01 %)
DIA $ 386.87 $ 4.54 (1.19 %)
SPY $ 511.25 $ 6.26 (1.24 %)
TLT $ 89.88 $ 0.90 (1.01 %)
GLD $ 212.97 $ -0.17 (-0.08 %)
$ 201.32
$ 201.29
$ 0.00 x 0
$ 0.00 x 0
$ 199.76 - $ 202.62
$ 177.96 - $ 233.32
555,654
na
17.82B
$ 1.09
$ 41.14
TBD
na
na ($ 0.01)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 04-30-2024 03-31-2024 10-Q
2 02-26-2024 12-31-2023 10-K
3 10-30-2023 09-30-2023 10-Q
4 08-04-2023 06-30-2023 10-Q
5 05-04-2023 03-31-2023 10-Q
6 02-28-2023 12-31-2022 10-K
7 11-01-2022 09-30-2022 10-Q
8 08-01-2022 06-30-2022 10-Q
9 04-29-2022 03-31-2022 10-Q
10 02-25-2022 12-31-2021 10-K
11 11-02-2021 09-30-2021 10-Q
12 08-05-2021 06-30-2021 10-Q
13 05-04-2021 03-31-2021 10-Q
14 02-25-2021 12-31-2020 10-K
15 10-29-2020 09-30-2020 10-Q
16 07-31-2020 06-30-2020 10-Q
17 05-08-2020 03-31-2020 10-Q
18 02-28-2020 12-31-2019 10-K
19 10-31-2019 09-30-2019 10-Q
20 08-08-2019 06-30-2019 10-Q
21 05-03-2019 03-31-2019 10-Q
22 02-28-2019 12-31-2018 10-K
23 10-30-2018 09-30-2018 10-Q
24 07-27-2018 06-30-2018 10-Q
25 05-01-2018 03-31-2018 10-Q
26 02-27-2018 12-31-2017 10-K
27 11-02-2017 09-30-2017 10-Q
28 08-02-2017 06-30-2017 10-Q
29 04-28-2017 03-31-2017 10-Q
30 02-27-2017 12-31-2016 10-K
31 10-28-2016 09-30-2016 10-Q
32 07-29-2016 06-30-2016 10-Q
33 05-06-2016 03-31-2016 10-Q
34 02-29-2016 12-31-2015 10-K
35 10-30-2015 09-30-2015 10-Q
36 07-30-2015 06-30-2015 10-Q
37 05-04-2015 03-31-2015 10-Q
38 02-26-2015 12-31-2014 10-K
39 11-10-2014 09-30-2014 10-Q
40 07-29-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
FDA Approves Labcorp's nAbCyte Anti-AAVRh7...
04/29/2024 11:04:45

analyst-ratings-for-laboratory-corp
Analyst Ratings For Laboratory Corp
04/26/2024 19:00:58

truist-securities-maintains-buy-on-laboratory-corp-lowers-price-target-to-255
Truist Securities Maintains Buy on Laborat...
04/26/2024 15:48:10

Truist Securities analyst Ryan MacDonald maintains Laboratory Corp (NYSE:LH) with a Buy and lowers the price target from $27...

barclays-maintains-equal-weight-on-laboratory-corp-lowers-price-target-to-213
Barclays Maintains Equal-Weight on Laborat...
04/26/2024 14:14:15

Barclays analyst Stephanie Davis maintains Laboratory Corp (NYSE:LH) with a Equal-Weight and lowers the price target from $2...

baird-maintains-outperform-on-laboratory-corp-lowers-price-target-to-244
Baird Maintains Outperform on Laboratory C...
04/26/2024 12:05:37

Baird analyst Eric Coldwell maintains Laboratory Corp (NYSE:LH) with a Outperform and lowers the price target from $255 to $...

labcorps-q1-revenue-surpasses-forecasts-analysts-scrutinize-invitae-deal
Labcorp's Q1 Revenue Surpasses Forecasts; ...
04/25/2024 19:04:27

Labcorp beats Q1 sales estimates, driven by organic growth and acquisitions. Revised 2024 guidance projects higher EPS and sale...

labcorp-expects-2024-adjusted-eps-of-1445-1535-versus-prior-guidance-of-1430-1540-and-consensus-of-1482
Labcorp Expects 2024 Adjusted EPS Of $14.4...
04/25/2024 11:16:58

laboratory-corp-q1-2024-adj-eps-368-beats-348-estimate-sales-3177b-beat-3117b-estimate
Laboratory Corp Q1 2024 Adj EPS $3.68 Beat...
04/25/2024 11:14:26

Laboratory Corp (NYSE:LH) reported quarterly earnings of $3.68 per share which beat the analyst consensus estimate of $3.48 by ...

Core News & Articles
Reported Earlier, Labcorp Wins Bid For Inv...
04/25/2024 07:28:40

Advances Labcorp strategy to launch and scale specialty testing in areas such as oncology and rare diseases Transaction requ...

labcorp-announced-the-availability-of-the-nations-first-test-for-glial-fibrillary-acidic-protein-a-critical-blood-based-biomarker-for-early-detection-of-neurodegenerative-diseases-and-neurological-injuries
Labcorp Announced The Availability Of The ...
04/15/2024 11:16:50

the-fda-granted-emergency-use-authorization-to-labcorps-mpox-pcr-test-home-collection-kit-to-diagnose-infection-with-non-variola-orthopoxvirus-as-the-first-mpox-at-home-collection-kit-authorized-by-fda
The FDA Granted Emergency Use Authorizatio...
04/10/2024 10:52:45

labcorp-reports-strategic-expansion-of-its-precision-oncology-portfolio
Labcorp Reports Strategic Expansion Of Its...
04/08/2024 11:11:09

Labcorp is expanding its portfolio of solutions that support the development of novel therapies for oncology with the launch of...

labcorp-launches-labcorp-plasma-detect-extending-leadership-into-molecular-residual-disease-mrd-clinical-research
Labcorp Launches Labcorp Plasma Detect Ext...
04/05/2024 11:02:07

The launch of the Labcorp Plasma Detect MRD solution further enhances Labcorp's leadership in precision oncology across the...

labcorp-expands-diagnostic-reach-with-strategic-deal-for-select-assets-of-bioreference-health
Labcorp Expands Diagnostic Reach With Stra...
03/28/2024 15:41:52

Labcorp acquires certain operations of Opko Health subsidiary BioReference Health. The assets Labcorp is acquiring generate abo...

Core News & Articles
Labcorp Announces Acquisition Of Select As...
03/28/2024 12:06:50

Transaction to enhance Labcorp's laboratory services network and expand access to the company's high-quality clinical l...

argus-research-upgrades-laboratory-corp-to-buy
Argus Research Upgrades Laboratory Corp to...
03/25/2024 11:42:53

Argus Research analyst David Toung upgrades Laboratory Corp (NYSE:LH) from Hold to Buy.

labcorp-announced-the-launch-and-immediate-availability-of-its-test-to-identify-the-presence-or-absence-of-phosphorylated-tau-217-blood-biomarker-to-aid-diagnosis-of-alzheimers-disease-and-subsequent-monitoring-of-patients-undergoing-treatment
Labcorp Announced The Launch And Immediate...
03/20/2024 11:06:39

reported-saturday-labcorp-presented-new-research-demonstrating-clinical-impact-of-precision-diagnostics-in-guiding-biomarker-targeted-therapies-for-patients-with-epithelial-ovarian-cancer
Reported Saturday, Labcorp Presented New R...
03/18/2024 06:32:20

Outcomes point to value of biomarker testing in addressing testing gaps in clinical practice

labcorp-introduces-its-weight-loss-management-portfolio
Labcorp Introduces Its Weight Loss Managem...
03/07/2024 12:05:11

The new offering features educational resources and convenient testing solutions, equipping individuals and their physicians wi...

leerink-partners-initiates-coverage-on-laboratory-corp-with-outperform-rating-announces-price-target-of-260
Leerink Partners Initiates Coverage On Lab...
02/26/2024 13:50:16

Leerink Partners analyst Michael Cherny initiates coverage on Laboratory Corp (NYSE:LH) with a Outperform rating and announc...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION